China Wants to Patent Gilead’s Experimental Coronavirus Drug
Bloomberg News
February 5, 2020
Chinese researchers have applied for a national patent on an experimental Gilead Sciences Inc. drug that they believe might fight the novel coronavirus.
The Wuhan Institute of Virology – based in the Chinese city at the center of the epidemic – has applied for a patent in China for the use of the antiviral drug, known as remdesivir, in treating the ailment. The application was made on Jan. 21 together with a military academy, according to a Feb. 4 statement on the institute’s website.
Link
https://www.bloomberg.com/news/articles/2020-02-05/china-is-trying-to-patent-gilead-s-experimental-coronavirus-drug
China Wants to Patent Gilead’s Experimental Coronavirus Drug
Bloomberg News
February 5, 2020
Chinese researchers have applied for a national patent on an experimental Gilead Sciences Inc. drug that they believe might fight the novel coronavirus.
The Wuhan Institute of Virology – based in the Chinese city at the center of the epidemic – has applied for a patent in China for the use of the antiviral drug, known as remdesivir, in treating the ailment. The application was made on Jan. 21 together with a military academy, according to a Feb. 4 statement on the institute’s website
.Link
China Wants to Patent Gilead’s Experimental Coronavirus Drug
Bloomberg News
February 5, 2020
Chinese researchers have applied for a national patent on an experimental Gilead Sciences Inc. drug that they believe might fight the novel coronavirus.
The Wuhan Institute of Virology – based in the Chinese city at the center of the epidemic – has applied for a patent in China for the use of the antiviral drug, known as remdesivir, in treating the ailment. The application was made on Jan. 21 together with a military academy, according to a Feb. 4 statement on the institute’s website.
China Wants to Patent Gilead’s Experimental Coronavirus Drug
Bloomberg News
February 5, 2020
Chinese researchers have applied for a national patent on an experimental Gilead Sciences Inc. drug that they believe might fight the novel coronavirus.
The Wuhan Institute of Virology – based in the Chinese city at the center of the epidemic – has applied for a patent in China for the use of the antiviral drug, known as remdesivir, in treating the ailment. The application was made on Jan. 21 together with a military academy, according to a Feb. 4 statement on the institute’s website.